NEO · Neogenomics Inc
$15.28
+1.88 (+14.03%)
At close · Jul 29
Market Cap
$1.99B
Shares
130.21M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Tony Zook | CEO | $9,127,092 |
| Warren Stone | President and Chief Operating Officer | $5,068,830 |
| Jeffrey Sherman | CFO | $4,681,428 |
| Christopher Smith | CEO | $4,045,937 |
| Melody Harris | Chief Operations Officer & President of Informatics | $3,692,445 |
| Alicia Olivo | General Counsel | $3,049,999 |
| Gary Passman | Chief Culture Officer | $2,443,195 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Christopher Smith | CEO | $11,338,487 |
| Jeffrey Sherman | CFO | $3,482,409 |
| Warren Stone | President and Chief Operating Officer | $3,184,486 |
| Melody Harris | Chief Operations Officer & President of Informatics | $2,875,377 |
| Vishal Sikri | President, Advanced Diagnostics | $2,282,360 |
| Alicia Olivo | General Counsel | $2,236,859 |
| Tony Zook | CEO | — |
| Gary Passman | Chief Culture Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Christopher Smith | CEO | $11,665,946 |
| Melody Harris | Chief Operations Officer & President of Informatics | $4,694,225 |
| Jeffrey Sherman | CFO | $3,547,358 |
| Warren Stone | President and Chief Operating Officer | $3,009,250 |
| Vishal Sikri | President, Advanced Diagnostics | $2,371,776 |
| Gary Passman | Chief Culture Officer | — |
| Alicia Olivo | General Counsel | — |
| Tony Zook | CEO | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Christopher Smith | CEO | $14,798,522 |
| Vishal Sikri | President, Advanced Diagnostics | $3,561,981 |
| Jeffrey Sherman | CFO | $3,266,154 |
| Warren Stone | President and Chief Operating Officer | $2,390,385 |
| Melody Harris | Chief Operations Officer & President of Informatics | — |
| Alicia Olivo | General Counsel | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Melody Harris | Chief Operations Officer & President of Informatics | — |
| Christopher Smith | CEO | — |
| Vishal Sikri | President, Advanced Diagnostics | — |
| Jeffrey Sherman | CFO | — |
| Warren Stone | President and Chief Operating Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Douglas M. VanOort | CEO | $4,122,039 |
| Robert J. Shovlin | President, Clinical Services | $1,297,308 |
| Dr. Lawrence M. Weiss | Chief Medical Officer | $1,285,000 |
| Douglas M. Brown | Chief Strategy and Corporate Development Officer | $1,246,154 |
| Kathryn B. McKenzie | CFO | $1,034,616 |
| Sharon A. Virag | CFO | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Douglas M. VanOort | CEO | $3,648,732 |
| Robert J. Shovlin | President, Clinical Services | $1,284,099 |
| Dr. Lawrence M. Weiss | Chief Medical Officer | $1,183,674 |
| George A. Cardoza | President and Chief Operating Officer, Laboratory Operations | $1,107,374 |
| Sharon A. Virag | CFO | $1,041,645 |
| Kathryn B. McKenzie | CFO | $524,844 |
| Douglas M. Brown | Chief Strategy and Corporate Development Officer | — |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Douglas M. VanOort | CEO | $3,347,219 |
| Robert J. Shovlin | President, Clinical Services | $1,328,739 |
| Sharon A. Virag | CFO | $1,093,562 |
| George A. Cardoza | President and Chief Operating Officer, Laboratory Operations | $1,056,522 |
| Dr. Lawrence M. Weiss | Chief Medical Officer | $855,895 |
| Kathryn B. McKenzie | CFO | — |
| Douglas M. Brown | Chief Strategy and Corporate Development Officer | — |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Douglas M. VanOort | CEO | $3,483,508 |
| Robert J. Shovlin | President, Clinical Services | $1,304,167 |
| George A. Cardoza | President and Chief Operating Officer, Laboratory Operations | $1,107,109 |
| Kathryn B. McKenzie | Chief Accounting Officer | — |
| Sharon A. Virag | CFO | — |
| Dr. Lawrence M. Weiss | Chief Medical Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Carolyn S. Starrett | director | Appointed | 2026-06-25 |
| Anthony P. Zook | member of the Board of Directors | Appointed | 2026-05-22 |
| Felicia Williams | member of the Board of Directors | Appointed | 2026-05-22 |
| David B. Perez | member of the Board of Directors | Appointed | 2026-05-22 |
| John P. Kenny | member of the Board of Directors | Appointed | 2026-05-22 |
| Michael A. Kelly | member of the Board of Directors | Appointed | 2026-05-22 |
| Stephen M. Kanovsky | member of the Board of Directors | Appointed | 2026-05-22 |
| Neil Gunn | member of the Board of Directors | Appointed | 2026-05-22 |
| Marjorie C. Green | member of the Board of Directors | Appointed | 2026-05-22 |
| Lynn A. Tetrault | member of the Board of Directors | Appointed | 2026-05-22 |
| Jeffrey S. Sherman | Executive Vice President, Finance | Appointed | 2026-01-12 |
| Jeffrey S. Sherman | Chief Financial Officer | Retired | 2026-01-12 |
Key facts
CIK
1077183
CUSIP
64049M209
13F (30d)
47 filings
47 filers
Visit website
Investor relations